Glaxo Smith Kline, a British multinational company that operates in the pharmaceutical sector, is to cut 4,000 jobs worldwide. The job-cuts will affect research units in Italy, United Kingdom, Croatia, Poland and Canada. The company announced a cost-saving plan that envisages the closure of its research units engaged in neuroscience research. As of February 2010, there is no confirmed information about the timeline but the measure will probably be implemented in the second half of 2010.
Glaxo has around 103,000 employees worldwide.